We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$1.62B
AUM Growth
+$208M
Cap. Flow
+$56.5M
Cap. Flow %
3.49%
Top 10 Hldgs %
23.27%
Holding
546
New
32
Increased
378
Reduced
121
Closed
11

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$3.98M
2
AMZN icon
Amazon
AMZN
+$3.04M
3
TSLA icon
Tesla
TSLA
+$2.66M
4
UNP icon
Union Pacific
UNP
+$2.66M
5
AAPL icon
Apple
AAPL
+$2.55M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.38M
2
CL icon
Colgate-Palmolive
CL
+$2.12M
3
MDT icon
Medtronic
MDT
+$1.61M
4
MRNA icon
Moderna
MRNA
+$1.56M
5
GNRC icon
Generac Holdings
GNRC
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 15.39%
3 Financials 11.91%
4 Consumer Discretionary 10.39%
5 Communication Services 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNPR
301
DELISTED
Juniper Networks
JNPR
$822K 0.05%
23,032
+1,170
+5% +$36.6K
FCX icon
302
Freeport-McMoran
FCX
$96.4B
$812K 0.05%
19,464
+1,847
+10% +$70.2K
EQR icon
303
Equity Residential
EQR
$24.4B
$807K 0.05%
8,913
+449
+5% +$38.6K
CMS icon
304
CMS Energy
CMS
$21.8B
$803K 0.05%
12,351
+370
+3% +$22.7K
PODD icon
305
Insulet
PODD
$10B
$792K 0.05%
2,976
+120
+4% +$34.8K
KEY icon
306
KeyCorp
KEY
$24.3B
$789K 0.05%
34,118
+4,264
+14% +$99K
BSX icon
307
Boston Scientific
BSX
$74.2B
$787K 0.05%
18,524
+1,748
+10% +$73.5K
SYF icon
308
Synchrony
SYF
$25.5B
$787K 0.05%
16,964
-247
-1% -$11.9K
IDXX icon
309
Idexx Laboratories
IDXX
$46.2B
$785K 0.05%
1,192
+98
+9% +$61.5K
MCO icon
310
Moody's
MCO
$82.5B
$782K 0.05%
2,003
+230
+13% +$88.7K
ERIE icon
311
Erie Indemnity
ERIE
$13.4B
$780K 0.05%
4,050
+2,350
+138% +$472K
PARA
312
DELISTED
Paramount Global Class B
PARA
$771K 0.05%
25,537
+530
+2% +$18.3K
ARE icon
313
Alexandria Real Estate Equities
ARE
$8.28B
$763K 0.05%
3,420
+180
+6% +$37.3K
ENPH icon
314
Enphase Energy
ENPH
$5.59B
$759K 0.05%
4,150
+186
+5% +$38.8K
LNT icon
315
Alliant Energy
LNT
$17.8B
$744K 0.05%
12,110
+300
+3% +$17.2K
NXPI icon
316
NXP Semiconductors
NXPI
$59.6B
$744K 0.05%
3,265
+279
+9% +$59.3K
MET icon
317
MetLife
MET
$61.5B
$742K 0.05%
11,868
+570
+5% +$35.8K
EIX icon
318
Edison International
EIX
$26.9B
$734K 0.05%
10,758
+90
+0.8% +$5.71K
BXP icon
319
Boston Properties
BXP
$10.8B
$726K 0.04%
6,305
-20
-0.3% -$2.3K
PWR icon
320
Quanta Services
PWR
$101B
$721K 0.04%
6,288
– –
MTD icon
321
Mettler-Toledo International
MTD
$28.8B
$713K 0.04%
420
+37
+10% +$55.9K
LYB icon
322
LyondellBasell Industries
LYB
$20.7B
$712K 0.04%
7,725
-423
-5% -$39.3K
STE icon
323
Steris
STE
$23.2B
$708K 0.04%
2,908
+1,752
+152% +$400K
BIIB icon
324
Biogen
BIIB
$30.1B
$703K 0.04%
2,929
+106
+4% +$27.3K
HIG icon
325
Hartford Financial Services
HIG
$38.1B
$700K 0.04%
10,132
+31
+0.3% +$2.19K
11 12
13
14 15

Similar funds

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return

Meiji Yasuda Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Meiji Yasuda Asset Management held 546 positions worth $1.62B, up 15% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meiji Yasuda Asset Management deployed $56.5M of net new capital in Q4 2021, opening 32 new positions and adding to 378 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,430 shares worth $548K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $2.38M trimmed.

  • Meiji Yasuda Asset Management's largest Q4 2021 buy was Neurocrine Biosciences: 6,430 shares worth $548K.
  • Meiji Yasuda Asset Management added most to Comcast in Q4 2021, an estimated $3.98M increase.
  • Meiji Yasuda Asset Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $2.38M.
  • Meiji Yasuda Asset Management fully exited News Corp Class A in Q4 2021, selling an estimated $1.2M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 23% of its $1.62B portfolio in Q4 2021.
  • Meiji Yasuda Asset Management opened 32 new positions and closed 11 in Q4 2021.
  • Meiji Yasuda Asset Management's portfolio value rose 15% quarter-over-quarter to $1.62B.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.